Rini BI - Search Results

1

Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma.

Lane BR, Derweesh IH, Kim HL, O'Malley R, Klink J, Ercole CE, Palazzi KL, Thomas AA, Rini BI, Campbell SC. Lane BR, et al. Among authors: rini bi. Urol Oncol. 2015 Mar;33(3):112.e15-21. doi: 10.1016/j.urolonc.2014.11.009. Epub 2014 Dec 19. Urol Oncol. 2015. PMID: 25532471 Clinical Trial.

2

New approaches in advanced renal cell carcinoma.

Rini BI. Rini BI. Urol Oncol. 2005 Jan-Feb;23(1):65-6. doi: 10.1016/j.urolonc.2004.10.007. Urol Oncol. 2005. PMID: 15885585 Review. No abstract available.

3

Renal cell carcinoma.

Rini BI, Campbell SC, Rathmell WK. Rini BI, et al. Curr Opin Oncol. 2006 May;18(3):289-96. doi: 10.1097/01.cco.0000219260.60714.c4. Curr Opin Oncol. 2006. PMID: 16552243 Review.

4

Sunitinib in patients with metastatic renal cell carcinoma.

Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD. Motzer RJ, et al. Among authors: rini bi. JAMA. 2006 Jun 7;295(21):2516-24. doi: 10.1001/jama.295.21.2516. JAMA. 2006. PMID: 16757724 Clinical Trial.

5

Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma.

Eisenberg MS, Meng MV, Master VA, Stoller ML, Rini BI, Carroll PR, Kane CJ. Eisenberg MS, et al. Among authors: rini bi. J Endourol. 2006 Jul;20(7):504-8. doi: 10.1089/end.2006.20.504. J Endourol. 2006. PMID: 16859465

6

Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports.

Shaheen PE, Rini BI, Bukowski RM. Shaheen PE, et al. Among authors: rini bi. Clin Genitourin Cancer. 2006 Jun;5(1):78-81. doi: 10.3816/CGC.2006.n.021. Clin Genitourin Cancer. 2006. PMID: 16859583

7

The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma.

Choueiri TK, Bukowski RM, Rini BI. Choueiri TK, et al. Among authors: rini bi. Semin Oncol. 2006 Oct;33(5):596-606. doi: 10.1053/j.seminoncol.2006.06.003. Semin Oncol. 2006. PMID: 17045089 Review.

8

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Among authors: rini bi. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

9

Molecularly targeted therapy in renal cell carcinoma: where do we go from here?

Rini BI. Rini BI. Expert Rev Anticancer Ther. 2006 Dec;6(12):1753-60. doi: 10.1586/14737140.6.12.1753. Expert Rev Anticancer Ther. 2006. PMID: 17181489 Review.

10

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, Reddy S, Dreicer R, Bukowski RM. Rini BI, et al. J Natl Cancer Inst. 2007 Jan 3;99(1):81-3. doi: 10.1093/jnci/djk008. J Natl Cancer Inst. 2007. PMID: 17202116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

523 results

Search Page

Filters